PDF(Pubmed)
Abstract：
BACKGROUND: Transurethral resection of bladder tumour (TURBT) is one of the more common procedures performed by urologists. It is often described as an \'incision-free\' and \'well-tolerated\' operation. However, many patients experience distress and discomfort with the procedure. Substantial opportunity exists to improve the TURBT experience. An enhanced recovery after surgery (ERAS) protocol designed by patients with bladder cancer and their providers has been developed.
METHODS: This is a single-centre, randomised controlled trial to investigate the effectiveness of an ERAS protocol compared with usual care in patients with bladder cancer undergoing ambulatory TURBT. The ERAS protocol is composed of preoperative, intraoperative and postoperative components designed to optimise each phase of perioperative care. 100 patients with suspected or known bladder cancer aged ≥18 years undergoing initial or repeat ambulatory TURBT will be enrolled. The change in Quality of Recovery 15 score, a measure of the quality of recovery, between the day of surgery and postoperative day 1 will be compared between the ERAS and control groups.
BACKGROUND: The trial has been approved by the Johns Hopkins Institutional Review Board #00392063. Participants will provide informed consent to participate before taking part in the study. Results will be reported in a separate publication.
BACKGROUND: NCT05905276.
METHODS: This is a single-centre, randomised controlled trial to investigate the effectiveness of an ERAS protocol compared with usual care in patients with bladder cancer undergoing ambulatory TURBT. The ERAS protocol is composed of preoperative, intraoperative and postoperative components designed to optimise each phase of perioperative care. 100 patients with suspected or known bladder cancer aged ≥18 years undergoing initial or repeat ambulatory TURBT will be enrolled. The change in Quality of Recovery 15 score, a measure of the quality of recovery, between the day of surgery and postoperative day 1 will be compared between the ERAS and control groups.
BACKGROUND: The trial has been approved by the Johns Hopkins Institutional Review Board #00392063. Participants will provide informed consent to participate before taking part in the study. Results will be reported in a separate publication.
BACKGROUND: NCT05905276.
摘要：
背景：经尿道膀胱肿瘤电切术（TURBT）是泌尿科医师最常见的手术之一。它通常被描述为“无切口”和“耐受性良好”的手术。然而,许多病人经历痛苦和不适的程序。存在改善TURBT体验的大量机会。已开发出由膀胱癌患者及其提供者设计的增强术后恢复（ERAS）方案。
方法：这是一个单中心，随机对照试验，以研究ERAS方案与常规治疗相比在接受门诊TURBT的膀胱癌患者中的有效性。ERAS协议由术前，术中和术后组件旨在优化围手术期护理的每个阶段。将招募100名年龄≥18岁的疑似或已知膀胱癌患者，接受初次或重复的动态TURBT。恢复质量15分的变化，恢复质量的衡量标准，在手术当天和术后第1天之间，将比较ERAS组和对照组。
背景：该试验已获得约翰·霍普金斯大学机构审查委员会#00392063的批准。参与者将在参与研究之前提供知情同意书。结果将在单独的出版物中报告。
背景：NCT05905276。
方法：这是一个单中心，随机对照试验，以研究ERAS方案与常规治疗相比在接受门诊TURBT的膀胱癌患者中的有效性。ERAS协议由术前，术中和术后组件旨在优化围手术期护理的每个阶段。将招募100名年龄≥18岁的疑似或已知膀胱癌患者，接受初次或重复的动态TURBT。恢复质量15分的变化，恢复质量的衡量标准，在手术当天和术后第1天之间，将比较ERAS组和对照组。
背景：该试验已获得约翰·霍普金斯大学机构审查委员会#00392063的批准。参与者将在参与研究之前提供知情同意书。结果将在单独的出版物中报告。
背景：NCT05905276。
